We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

98 hedge funds and large institutions have $167M invested in Five Prime Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 33 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more capital invested

Capital invested by funds: $57.9M → $167M (+$109M)

165% more call options, than puts

Call options by funds: $567K | Put options by funds: $214K

120% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 10

13% more funds holding

Funds holding: 87 → 98 (+11)

9% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 33

Holders
98
Holders Change
+11
Holders Change %
+12.64%
% of All Funds
2.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
30
Reduced
33
Closed
10
Calls
$567K
Puts
$214K
Net Calls
+$353K
Net Calls Change
+$1.2M

Top Buyers

1
CS
Candriam SCA
Luxembourg
+$2.07M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$1.84M
3
ECM
Endurant Capital Management
California
+$977K
4
JMPWA
JP Morgan Private Wealth Advisors
California
+$955K
5
PPA
Parametric Portfolio Associates
Washington
+$942K

Top Sellers

1
BlackRock
BlackRock
New York
-$1.49M
2
Renaissance Technologies
Renaissance Technologies
New York
-$939K
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$568K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$545K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$433K
Name Holding Trade Value Shares
Change 		Change in
Stake
Man Group
26
Man Group
United Kingdom
$1.32M -$69.6K -16,899 -7%
Charles Schwab
27
Charles Schwab
California
$1.3M -$5.31K -1,289 -0.6%
JP Morgan Chase
28
JP Morgan Chase
New York
$1.15M -$65.1K -15,813 -8%
BCM
29
Bridgeway Capital Management
Texas
$1.02M +$185K +45,000 +37%
Goldman Sachs
30
Goldman Sachs
New York
$1.01M +$477K +115,767 +234%
Invesco
31
Invesco
Georgia
$987K +$406K +98,442 +155%
N
32
Nuveen
North Carolina
$814K -$104K -25,368 -16%
Citadel Advisors
33
Citadel Advisors
Florida
$809K +$14.9K +3,617 +3%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$753K -$68.4K -16,616 -12%
HIM
35
Hillsdale Investment Management
Ontario, Canada
$744K +$502K +121,900 New
SG Americas Securities
36
SG Americas Securities
New York
$652K +$191K +46,336 +76%
Macquarie Group
37
Macquarie Group
Australia
$610K – – –
PAM
38
Panagora Asset Management
Massachusetts
$562K +$370K +89,943 +4,118%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$553K +$222K +53,882 +147%
AGA
40
Altrinsic Global Advisors
Connecticut
$549K – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$458K +$47.4K +11,500 +18%
UBS Group
42
UBS Group
Switzerland
$357K +$155K +37,531 +179%
ECM
43
ExodusPoint Capital Management
New York
$330K +$223K +54,094 New
Ameriprise
44
Ameriprise
Minnesota
$315K +$212K +51,547 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$314K -$32.4K -7,875 -13%
FSA
46
Franklin Street Advisors
North Carolina
$305K – – –
FAM
47
Fred Alger Management
New York
$305K – – –
Wells Fargo
48
Wells Fargo
California
$275K +$48.7K +11,827 +36%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$246K -$30.2K -7,341 -15%
PP
50
PDT Partners
New York
$236K -$125K -30,350 -44%
1
2
3 4 5

FPRX Hedge Fund Activity: Q2 2020 in Review

98 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q2 2020, worth a combined $167M — up 188% from $57.9M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FPRX positions and 10 closed out — a net gain of 12 holders — while 30 added to existing stakes and 33 trimmed.

The largest buyer was Candriam SCA, adding an estimated $2.07M. The largest seller was BlackRock, cutting an estimated $1.49M.

  • 98 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q2 2020, up from 87 in Q1 2020.
  • Funds reported $167M of Five Prime Therapeutics, Inc. stock for Q2 2020, up 188% quarter-over-quarter.
  • 22 funds opened new Five Prime Therapeutics, Inc. positions in Q2 2020 and 10 closed out, a net change of +12 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q2 2020 was Candriam SCA, an estimated $2.07M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q2 2020 was BlackRock, an estimated $1.49M sold.

Based on aggregated 13F filings for Q2 2020.